These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4517839)

  • 1. Portal diversion for the treatment of glycogen storage disease in humans.
    Starzl TE; Putnam CW; Porter KA; Halgrimson CG; Corman J; Brown BI; Gotlin RW; Rodgerson DO; Greene HL
    Ann Surg; 1973 Oct; 178(4):525-39. PubMed ID: 4517839
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the effects of total parenteral nutrition, continuous intragastric feeding, and portacaval shunt on a patient with type I glycogen storage disease.
    Burr IM; O'Neill JA; Karzon DT; Howard LJ; Greene HL
    J Pediatr; 1974 Dec; 85(6):792-5. PubMed ID: 4213651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-biochemical and morphological characteristics of the hepatic form of glycogenosis in children].
    Popovich IuG; Chibisov IV; Potapova-Vinogradova IN; Chistova LV
    Pediatriia; 1988; (1):35-9. PubMed ID: 3163143
    [No Abstract]   [Full Text] [Related]  

  • 4. Portal diversion in glycogen storage disease.
    Starzl TE; Brown BI; Blanchard H; Brettschneider L
    Surgery; 1969 Mar; 65(3):504-6. PubMed ID: 4303854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Portal shunts in metabolic liver diseases].
    Bismuth H; Franco D; Grange D
    Gastroenterol Clin Biol; 1977; 1(11):903-16. PubMed ID: 340317
    [No Abstract]   [Full Text] [Related]  

  • 6. Low molecular weight glycogen as a cause of generalized glycogen storage disease.
    Krivit W; Sharp HL; Lee JC; Larner J; Edstrom R
    Am J Med; 1973 Jan; 54(1):88-97. PubMed ID: 4345263
    [No Abstract]   [Full Text] [Related]  

  • 7. Portacaval shunt for glycogen storage disease: value of prolonged intravenous hyperalimentation before surgery.
    Folkman J; Philippart A; Tze WJ; Crigler J
    Surgery; 1972 Aug; 72(2):306-14. PubMed ID: 4626293
    [No Abstract]   [Full Text] [Related]  

  • 8. Portacaval shunt in the treatment of glycogen storage disease: report of a case.
    Hermann RE; Mercer RD
    Surgery; 1969 Mar; 65(3):499-503. PubMed ID: 5250067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surgical treatment of glycogenosis].
    Kozaka S; Nishio I; Mizukami T
    Bruns Beitr Klin Chir (1971); 1969 Jun; 217(4):337-42. PubMed ID: 5264200
    [No Abstract]   [Full Text] [Related]  

  • 10. Portacaval shunt for glycogen storage disease and hyperlipidaemia.
    Starzl TE; Putnam CW; Porter KA; Benichou J
    Ciba Found Symp; 1977; (55):311-25. PubMed ID: 207496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease treated by portacaval transposition.
    Ridell AG; Davies RP
    Proc R Soc Med; 1966 Jun; 59(6):484. PubMed ID: 5220251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgical therapy of metabolic liver diseases (glycogenosis, hypercholesterolemia)].
    Meriggi F; Forni E; Bismuth H
    G Chir; 1998 Mar; 19(3):79-84. PubMed ID: 9577079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    STARZL TE; MARCHIORO TL; SEXTON AW; ILLINGWORTH B; WADDELL WR; FARIS TD; HERRMANN TJ
    Surgery; 1965 May; 57():687-97. PubMed ID: 14295780
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver glycogenosis with cirrhosis without enzyme deficiency].
    Salle B; Mathieu M; Bonnassieu M; Hollard D; Monnet P; Ruitton-Uglienco
    Arch Fr Pediatr; 1972 Jan; 29(1):67-78. PubMed ID: 4504125
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver glycogenosis. A biochemical and ultrastructural study.
    De Bruijn WC; Fernandes J; Huber J; Koster JF
    Pathol Eur; 1975; 10(1):3-15. PubMed ID: 170575
    [No Abstract]   [Full Text] [Related]  

  • 16. The Eck fistula in animals and humans.
    Starzl TE; Porter KA; Francavilla A
    Curr Probl Surg; 1983 Nov; 20(11):687-752. PubMed ID: 6357642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III glycogenosis with deposition of urate and amyloid.
    Kawaguchi Y; Shirasawa K; Yotsumoto S; Nagahara S
    Acta Pathol Jpn; 1980 Jul; 30(4):599-612. PubMed ID: 6998254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked glycogen storage disease. A cause of hypotonia, hyperuricemia, and growth retardation.
    Keating JP; Brown BI; White NH; DiMauro S
    Am J Dis Child; 1985 Jun; 139(6):609-13. PubMed ID: 3859203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal diversion. Treatment for glycogen storage disease and hyperlipemia.
    Starzl TE; Putnam CW
    JAMA; 1975 Sep; 233(9):955-7. PubMed ID: 168416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism studies in children and young adults with glycogenoses].
    Matschke I; Neubaur J; Willms B; Wolf H
    Monatsschr Kinderheilkd (1902); 1969 Apr; 117(4):259-62. PubMed ID: 5270571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.